Connect with us
The Spanish company Exheus has recently opened a financing round in order to launch into the European market. The functioning of Exheus tests is based on...
Integra Therapeutics will allocate the funds to the development of the FiCAT platform prototype and preclinical validation. The Catalan company has also raised sufficient capital to...
The capital raised by Kither Biotech will be used to fund the development of Kither's lead product (Kit2014), a novel cell-permeable peptide for the treatment of...
The figures in the pharmaceuticals area are cemented especially by the performance of Bayer's cardiovascular treatments and for the prevention of age-related ophthalmological diseases. Another highlight...
Pfizer is the only company that has a pneumococcal vaccine in Spain with an indication from six weeks of age. The tender budget has been determined...
Miwendo receives funds from the European Union (EU) to advance in cancer detection. Colorectal cancer is the most prevalent cancer in Spain and, worldwide, 1.4 million...
In the fourth quarter of 2021, Moderna achieved a profit of $4.87 billion compared with a loss of $272 million in 2020. Total revenue increased from...
With the publication of the results of this trial, which will probably take place in March or April, Neurofix Pharma will increase its valuation and will...
With the $57 million (€50 million), SpliceBio aims to bring this strategy to the clinical phase (human trials) in about 2 to 3 years. Its aim...
Pfizer, Johnson&Johnson (J&J) and AstraZeneca achieved a combined profit of $42.972 billion in 2021, up from $27.017 billion a year earlier, according to results released by...
 |
|
 |  |
 |
|